Acurx Pharmaceuticals Inc (NASDAQ: ACXP)’s stock price has gone rise by 5.23 in comparison to its previous close of 3.44, however, the company has experienced a -3.47% decrease in its stock price over the last five trading days. PRNewsWire reported 2023-08-22 that STATEN ISLAND, N.Y., Aug. 22, 2023 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that David P.
Is It Worth Investing in Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Right Now?
while the 36-month beta value is -1.86.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price point forecasted by analysts for Acurx Pharmaceuticals Inc (ACXP) is $12.33, which is $8.71 above the current market price. The public float for ACXP is 11.15M, and currently, short sellers hold a 8.49% ratio of that floaft. The average trading volume of ACXP on November 17, 2023 was 731.54K shares.
ACXP’s Market Performance
The stock of Acurx Pharmaceuticals Inc (ACXP) has seen a -3.47% decrease in the past week, with a -37.15% drop in the past month, and a 94.62% gain in the past quarter. The volatility ratio for the week is 10.52%, and the volatility levels for the past 30 days are at 15.57% for ACXP. The simple moving average for the past 20 days is -15.00% for ACXP’s stock, with a 25.65% simple moving average for the past 200 days.
ACXP Trading at 16.97% from the 50-Day Moving Average
After a stumble in the market that brought ACXP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.96% of loss for the given period.
Volatility was left at 15.57%, however, over the last 30 days, the volatility rate increased by 10.52%, as shares sank -27.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +104.52% upper at present.
During the last 5 trading sessions, ACXP fell by -3.47%, which changed the moving average for the period of 200-days by +1.69% in comparison to the 20-day moving average, which settled at $4.19. In addition, Acurx Pharmaceuticals Inc saw -9.05% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ACXP
The total capital return value is set at -122.61, while invested capital returns managed to touch -122.61. Equity return is now at value -185.78, with -140.57 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.55.
Conclusion
In a nutshell, Acurx Pharmaceuticals Inc (ACXP) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
